Mycoplasma pneumoniae-induced cutaneous disease

International Journal of Dermatology

Volumn 48, Issue 7, 2009, Pages 673-681

  Schalock, Peter C ^a,b   Dinulos, James G H ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; CORTICOSTEROID; ERYTHROMYCIN; IMMUNOGLOBULIN; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; TRIAMCINOLONE;

ANTIBODY PRODUCTION; BACTERIAL SKIN DISEASE; BACTERIUM EXAMINATION; CAUSAL ATTRIBUTION; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG ERUPTION; DRUG INDICATION; ERYTHEMA MULTIFORME; ERYTHEMA NODOSUM; HUMAN; LEUKOCYTOCLASTIC VASCULITIS; MACULOPAPULAR RASH; MEASLES LIKE RASH; MUCOCUTANEOUS LYMPH NODE SYNDROME; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; MYCOPLASMOSIS; NONHUMAN; PAPULAR RASH; PITYRIASIS ROSEA; RAYNAUD PHENOMENON; REITER SYNDROME; REVIEW; STEVENS JOHNSON SYNDROME; SUBCORNEAL PUSTULAR DERMATOSIS; THROMBOTIC THROMBOCYTOPENIC PURPURA; URTICARIA;

DISEASE OUTBREAKS; EDUCATION, MEDICAL, CONTINUING; HUMANS; INCIDENCE; MYCOPLASMA INFECTIONS; MYCOPLASMA PNEUMONIAE; PREVALENCE; SKIN DISEASES, BACTERIAL;

EID: 67649216833     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2009.04154.x     Document Type: Review

References (46)

1. Daxboeck F, Kircher K, Krause R. Effect of age on antibody titer to Mycoplasma pneumoniae. Scand J Infect Dis 2002; 34: 577-579.
2. Rastawicki W, Kaluzewski S, Jagielski M, et al. Epidemiology of Mycoplasma pneumoniae infections in Poland: 28 years of surveillance in Warsaw, 1970-1997. Eurosurveillance 1998; 3: 99-100.
3. Mogabgab WJ. Mycoplasma pneumoniae and adenovirus respiratory illnesses in military and university personnel, 1959-1966. Am Rev Resp Dis 1968; 97: 345-358.
4. Baum SG. Mycoplasma pneumoniae and atypical pneumonia. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases, 5th edn. New York, NY: Churchill-Livingstone, 2000: 2020-2025.
5. Murray HW, Masur H, Senterfit LB, et al. The protean manifestations of Mycoplasma pneumoniae in adults. Am J Med 1975; 58: 229-241.
6. Copps SC, Allen VD, Sueltmann S, et al. A community outbreak of Mycoplasma pneumoniae. J Am Med Assoc 1968; 204: 123-128.
7. Atkinson TP, Balish MF, Waites KB. Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. FEMS Microbiol Rev 2008; 32: 956-973.
8. Ravel R. Clinical laboratory medicine. In: Ravel R, ed. Clinical Laboratory Medicine: Clinical Application of Laboratory Data, 6th edn. New York: Mosby Yearbook, Inc., 1995: 208-209.
9. Drasbek M, Nielsen PK, Persson K, et al. Immune response to Mycoplasma pneumoniae P1 and P116 in patients with atypical pneumonia analyzed by ELISA. BMC Microbiol 2004; 4: 7.
10. Ferwerda A, Moll HA, de Groot R. Respiratory tract infections by Mycoplasma pneumoniae in children: A review of diagnostic and therapeutic measures. Eur J Pediatr 2001; 160: 483-491.
11. Sánchez-Vargas FM, Gómez-Duarte OG. Mycoplasma pneumoniae - An emerging extra-pulmonary pathogen. Clin Microbiol Infect 2008; 14 (2): 105-117.
12. Kano Y, Mitsuyama Y, Hirahara K, et al. Mycoplasma pneumoniae infection-induced erythema nodosum, anaphylactoid purpura, and acute urticaria in 3 people in a single family. J Am Acad Dermatol 2007; 57: S33-S35.
13. Cherry JD. Anemia and mucocutaneous lesions due to Mycoplasma pneumoniae infections. Clin Infect Dis 1993; 17: S47-S51.
14. Macfarlane J. Mycoplasma pneumoniae infection, antibiotics and exanthema. Infection 1980; 8: 119-120.
15. Harris JA, Kolokathis A, Campbell M, et al. Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children. Pediatr Infect Dis J 1998; 17: 865-871.
16. Prandota J. Important role of prodromal viral infections responsible for inhibition of xenobiotic metabolizing enzymes in the pathomechanism of idiopathic Reye's syndrome, Stevens-Johnson syndrome, autoimmune hepatitis, and hepatotoxicity of the therapeutic doses of acetaminophen used in genetically predisposed persons. Am J Ther 2002; 9: 149-156.
17. Cohen JI. Epstein-Barr infections. In: Freedberg IM, Eisen AZ, Wolff K, et al., ed. Dermatology in General Medicine. New York, NY: McGraw-Hill, 2003: 2095-2096
18. Kakourou T, Drosatou P, Psychou F, et al. Erythema nodosum in children: a prospective study. J Am Acad Dermatol 2001; 44: 17-21.
19. Magro CM, Crowson AN. A distinctive cutaneous reaction pattern indicative of infection by reactive arthropathy-associated microbial pathogens: The superantigen ID reaction. J Cutan Pathol 1998; 25: 538-544.
20. Doeglas HMG, Rijnten WJ, Schroeder FP, et al. Cold urticaria and virus infections: A clinical and serological study in 39 patients. Br J Dermatol 1986; 114: 311-318.
21. Bilbao A, Garcia JM, Pocheville I, et al. Round table: Urticaria in relation to infections. Allergol Immunopathol (Madr) 1999; 27: 73-85.
22. Schalock PC, Brennick JB, Dinulos JG. Mycoplasma pneumoniae infection associated with bullous erythema multiforme. J Am Acad Dermatol 2005; 52: 705-706.
23. Tay YK, Huff JC, Weston WL. Mycoplasma pneumoniae infection is associated with Stevens-Johnson syndrome, not erythema multiforme (von Hebra). J Am Acad Dermatol 1996; 35: 757-760.
24. Schalock PC, Dinulos JGD, Pace NC, et al. "Erythema multiforme" due to Mycoplasma pneumoniae infection in two children. Pediatr Dermatol 2006; 23: 546-555.
25. Zipitis CS, Thalange N. Intravenous immunoglobulins for the management of Stevens-Johnson syndrome with minimal skin manifestations. Eur J Pediatr 2007; 166: 585-588.
26. Ravin KA, Rappaport LD, Zuckerbraun NS, et al. Mycoplasma pneumoniae and atypical Stevens-Johnson syndrome: A case series. Pediatrics 2007; 119: e1002-e1005.
27. Fearon D, Hesketh EL, Mitchell AE, et al. Mycoplasma pneumoniae infection complicated by pneumomediastinum and severe mucositis. J Paediatr Child Health 2007; 43: 403-405.
28. Latsch K, Girschick HJ, Abele-Horn M. Stevens-Johnson syndrome without skin lesions. J Med Microbiol 2007; 56: 1696-1699.
29. Ghislain PD, Roujeau JC. Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome. Dermatol Online J 2002; 8: 5.
30. Grayston JT, Alexander ER, Kenny GE, et al. Mycoplasma pneumoniae infections: Clinical and epidemiological studies. J Am Med Assoc 1965; 191: 97-102.
31. Feizi T, Maclean H, Sommerville RG, et al. Studies on an epidemic of respiratory disease caused by Mycoplasma pneumoniae. Br Med J 1967; 1: 457-460.
32. Ishibashi A, Ueda I, Fujita K. Pityriasis rosea Gibert and Mycoplasma pneumoniae infection. J Dermatol 1985; 12: 97-100.
33. Chuh AAT, Chan HHL. Prospective case-control study of Chlamydia, Legionella and Mycoplasma infections in patients with pityriasis rosea. Eur J Dermatol 2002; 12: 170-173.
34. Cole BC. The immunobiology of Mycoplasma arthritidis and its superantigen MAM. Curr Top Microbiol Immunol 1991; 174: 107-119.
35. Leen C, Ling S. Mycoplasma infection and Kawasaki disease. Arch Dis Child 1996; 75: 266-267.
36. Wang JN, Wang SM, Liu CC, et al. Mycoplasma pneumoniae infection associated with Kawasaki disease. Acta Paediatr 2001; 90: 594-595.
37. Narita M, Yamada S, Nakayama T, et al. Two cases of lymphadenopathy with liver dysfunction due to Mycoplasma pneumoniae infection with mycoplasmal bacteraemia without pneumonia. J Infect 2001; 42: 154-156.
38. Greco F, Sorge A, Salvo V, et al. Cutaneous vasculitis associated with Mycoplasma pneumoniae infection: Case report and literature review. Clin Pediatr (Phila) 2007; 46: 451-453.
39. Said MH, Layani MP, Colon S, et al. Mycoplasma pneumoniae-associated nephritis in children. Pediatr Nephrol 1999; 13: 39-44.
40. Bar Meir E, Amital H, Levy Y, et al. Mycoplasma pneumoniae-induced thrombotic thrombocytopenic purpura. Acta Haematol 2000; 103: 112-115.
41. Winnock T, Wang J, Suys E, et al. Vesiculopustular eruption associated with Mycoplasma pneumoniae pneumopathy. Dermatology 1996; 192: 73-74.
42. Reichert-Penetrat S, Barbaud A, Antunes A, et al. An unusual form of Stevens-Johnson syndrome with subcorneal pustules associated with Mycoplasma pneumoniae infection. Pediatr Dermatol 2000; 17: 202-204.
43. Sneddon IB. Subcorneal pustules in erythema multiforme. Br J Dermatol 1973; 88 (6): 605-607.
44. Furioli J, Bourdon C, Le Loc'h H. Mycoplasma pneumoniae infection. Manifestation in a 3-year-old child by Raynaud's phenomenon. Arch Fr Pediatr 1985; 42: 313-314.
45. Natarajan RU, Tan TL, Lau R. Reiter's disease following Mycoplasma pneumoniae infection. Int J STD AIDS 2001; 12: 349-350.
46. Manoharan S, Muir J, Williamson R. Gianotti-Crosti syndrome in an adult following recent Mycoplasma pneumoniae infection. Australas J Dermatol 2005; 46: 106-109.